Abstract: A composition comprising a physically discrete pet food oral intake composition coated with a physically stable film, the film comprising a component which is a) capable of carrying a beneficial agent to a site in the pet wherein the benefit agent is effective in producing a beneficial effect or b) capable of releasing the benefit agent into the mouth or alimentary canal with the benefit agent traveling to a site in the pet wherein the benefit agent is effective in producing a beneficial effect.

Abstract: A composition comprising a physically discrete pet food oral intake composition coated with a physically stable film, the film comprising a component which is a) capable of carrying a beneficial agent to a site in the pet wherein the benefit agent is effective in producing a beneficial effect or b) capable of releasing the benefit agent into the mouth or alimentary canal with the benefit agent traveling to a site in the pet wherein the benefit agent is effective in producing a beneficial effect.

Abstract: A composition comprising a physically discrete pet food oral intake composition coated with a physically stable film, the film comprising a component which is a) capable of carrying a beneficial agent to a site in the pet wherein the benefit agent is effective in producing a beneficial effect or b) capable of releasing the benefit agent into the mouth or alimentary canal with the benefit agent traveling to a site in the pet wherein the benefit agent is effective in producing a beneficial effect.

Abstract: A composition comprising a physically discrete pet food oral intake composition coated with a physically stable film, the film comprising a component which is a) capable of carrying a beneficial agent to a site in the pet wherein the benefit agent is effective in producing a beneficial effect or b) capable of releasing the benefit agent into the mouth or alimentary canal with the benefit agent traveling to a site in the pet wherein the benefit agent is effective in producing a beneficial effect.

Abstract: A method for reducing the amount of a proinflammatory substance present at an elevated level in animal tissue or body fluid by orally administering to the animal a proinflammatory substance reducing amount of a composition comprising at least one omega-3 fatty acid. The method is useful for reducing inflammation caused by elevated levels of proinflammatory substances including inflammation associated with an oral condition.

Abstract: A gingival contour probe comprising a shaft portion and an elongated tip portion attached at a proximal end thereof to the shaft portion, the tip portion being non-planarly bent and/or curved and carrying markings, the number and scale of which are indicative of measured lengths; the probe being adapted at least by the number and/or scale of the markings for use in convenient gingival margin measurement of a tooth in a conscious non-human animal. A method for quantifying dental plaque in a conscious non-human animal comprising (a) aligning the tip portion of such a gingival contour probe with a gingival margin of a tooth in the animal; (b) by reference to the markings on the tip portion of the probe, measuring the length of the margin and the length of plaque deposit if any at the margin; and (c) calculating a plaque score for the tooth by comparing the length of plaque deposit with the length of the margin.